Ramón Salinas

Immunology and Microbiology · Life Sciences

13h-index567citations40works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Complement system in diseases(8), COVID-19 Clinical Research Studies(4), Atrial Fibrillation Management and Outcomes(4), Venous Thromboembolism Diagnosis and Management(4), Bariatric Surgery and Outcomes(4)

Publications40 total

La isla en pozo: Una lectura de arena y agua
Revista Ciencia y Cultura·2024Open Access
Minimally Invasive Posterolateral Transcavernous Transtentorial Approach: 2-Dimensional Operative Video
Operative Neurosurgery·2023· 2 cited
Edoxaban vs low molecular weight heparin in COVID-19 hospitalized patients with atrial fibrillation
Research Square (Research Square)·2023Open Access
Edoxaban Versus Low-Molecular-Weight Heparin in Hospitalized COVID-19 Patients With Atrial Fibrillation
Clinical and Applied Thrombosis/Hemostasis·2023· 3 citedOpen Access
Real-world effectiveness of caplacizumab vs the standard of care in immune thrombotic thrombocytopenic purpura
Blood Advances·2022· 50 citedOpen Access
Recommendations for the diagnosis and treatment of patients with thrombotic thrombocytopenic purpura
Medicina Clínica (English Edition)·2022· 6 cited
Mortality in acquired thrombotic thrombocytopenic purpura in the pre-caplacizumab era
Annals of Hematology·2021· 13 cited
Recomendaciones para el abordaje clínico de pacientes con púrpura trombocitopénica trombótica
Medicina Clínica·2021· 20 cited
Incidence, diagnosis, and outcome of immune‐mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura
Journal of Clinical Apheresis·2021· 21 cited
Multicentric evaluation of the new HemosIL Acustar<sup>®</sup> chemiluminescence ADAMTS13 activity assay
International Journal of Laboratory Hematology·2020· 20 cited
Edoxaban Vs. Low Molecular Weight Heparin As Anticoagulant Therapy in Hospitalized Patients with Atrial Fibrillation and COVID-19 Infection
Blood·2020· 3 citedOpen Access
Management of Secondary Prevention in Venous Thromboembolism: Use of Reduced Doses of Rivaroxaban and Apixaban in Extended Therapy
Blood·2020
The Elevation of LIVER Enzymes in Patients with Atrial Fibrillation and COVID-19 Is a Marker of Bad Evolution and Mortality
Blood·2020Open Access
&lt;em&gt;EL SOCHANTRE PRÁCTICO DE LA CATEDRAL DE HUESCA&lt;/em&gt; (1868) DEL MAESTRO DE CAPILLA CELESTINO VILA DE FORNS (*1830 - †1915)
Revista de Musicología·2020
Effectiveness and Safety of Direct Oral Anticoagulants Vs. Low Molecular Weight Heparin As Anticoagulant Therapy in Patients with Active Cancer Therapy and Non Valvular Atrial Fibrillation
Blood·2019· 2 cited
Anticoagulation Challenges in Hematogeriatrics: Effectiveness and Safety of Direct Oral Anticoagulants Vs Vitamin k Antagonist in Elderly with Atrial Fibrillation
Blood·2019
Incidence, Diagnosis, and Outcome of Acquired Thrombotic Thrombocytopenic Purpura (aTTP): A Nationwide Survey By the Spanish Apheresis Group
Blood·2019· 4 cited
Factors Associated with Mortality in Patients Experiencing First Episodes of Acquired Thrombotic Thrombocytopenic Purpura (aTTP). Results of the Spanish TTP Registry
Blood·2019
Direct Oral Anticoagulant Vs Vitamin K Antagonist As Anticoagulant Therapy in Patients with Inherited and Acquired Thrombophilia
Blood·2018· 1 cited
Cáncer de pene: experiencia en 6 casos del Hospital de Curicó entre los años 2013-2015
Revista Chilena de Estudiantes de Medicina·2016Open Access
page 1 of 2Next →

Frequent Co-authors

Julio del Río-Garma(8), Pável Olivera(8), Katia Flores(8), Javier de la Rubia(7), Desirée Campoy(7), Tania Canals(7), Cristina Pascual(6), César A Velasquez(6), Jorge Sierra(6), María Eva Mingot‐Castellano(5), Joan Cid(5), Faustino García‐Candel(5), José María García‐Gala(5), Erik Johansson(5), Aurora Viejo(4), Ana Oliva(4), Gonzalo Artaza(4), David Valcárcel(3), Inés Gómez‐Seguí(3), Rosa Goterris(3)